USPTO serial 79278674
VIROKEY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- GOLDEN, LAURA DAWN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VIROKEY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Trevor P. Schmidt
Trevor P. Schmidt HUTCHISON PLLC701 Corporate Center DriveSuite 250Raleigh, NC 27612Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical substances used in industry and for scientific and research and in vitro diagnostics purposes, including scientific and research purposes, namely, diagnostic preparations other than for human medicine and veterinary medicine purposes, reagents and solvents for research and in vitro diagnostics, and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research and in vitro diagnostics, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; kits consisting primarily of protein assays and chemical reagents for scientific and research and in vitro diagnostics purposes, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for detection and treatment of viral infections and respiratory illnesses; dietetic foods and beverages adapted for medical use; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical use | ACTIVE | — |
| 035 | data processing services; all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vela Diagnostics Holding Pte. Ltd.
- Other trademarks owned by Vela Diagnostics Holding Pte. Ltd.
- Other trademarks owned by Vela Diagnostics Holding Pte. Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named VIROKEY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 16, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 26, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 26, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 21, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 21, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 21, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 29, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Aug 6, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 26, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 3, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 18, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 28, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 13, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |